Evolution and governance of the biotechnology and pharmaceutical industry of China-Reference-Cited by-同舟云学术

Evolution and governance of the biotechnology and pharmaceutical industry of China

Published:2009-05 Issue:9 Volume:79 Page:2947-2956
ISSN:0378-4754
Container-title:Mathematics and Computers in Simulation
language:en
Short-container-title:Mathematics and Computers in Simulation

Author:

Wang Kai,Hong Jin,Marinova Dora,Zhu Liang

Publisher

Elsevier BV

Subject

Applied Mathematics,Modelling and Simulation,Numerical Analysis,General Computer Science,Theoretical Computer Science

Reference25 articles.

1. The Science Studies Reader;Biagioli;Routledge,1999

2. China’s leap forward in biotechnology;Breithaupt;EMBO Reports,2003

3. Mapping the Dynamics of Science and Technology,1986

4. Report on Development of Chinese Bio-technology, 2002;Department of High Technology Industry Development of Commission of National Development Planning, and Chinese Academy of Bioengineering (DHTID),2003

5. H. Ding, Bio-industry R&D in China, Finpro Tekes China Silk Road Biotech Project, Finpro Shanghai, June (2007).

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of education attention on high-tech markets in an emerging economy: Evidence from QQR and NCQ techniques;Technological Forecasting and Social Change;2024-10

2. Governance forms of the pharmaceutical supply chain of Bogota, Colombia;Socio-Economic Planning Sciences;2024-04

3. Impact of government subsidies on innovation of Chinese biopharmaceutical firms: Based on kink threshold model;Frontiers in Public Health;2023-02-23

4. INNOVATION DIVIDE IN THE WORLD ECONOMY: CHINA’S CONVERGENCE TOWARDS THE TRIAD;Technological and Economic Development of Economy;2022-06-09

5. Evaluation model of bus routes optimization scheme based on multi-source bus data;Transportation Research Interdisciplinary Perspectives;2021-06